[go: up one dir, main page]

AP2283A - Stable aqueous suspension. - Google Patents

Stable aqueous suspension.

Info

Publication number
AP2283A
AP2283A AP2008004691A AP2008004691A AP2283A AP 2283 A AP2283 A AP 2283A AP 2008004691 A AP2008004691 A AP 2008004691A AP 2008004691 A AP2008004691 A AP 2008004691A AP 2283 A AP2283 A AP 2283A
Authority
AP
ARIPO
Prior art keywords
aqueous suspension
stable aqueous
stable
suspension
aqueous
Prior art date
Application number
AP2008004691A
Other languages
English (en)
Other versions
AP2008004691A0 (en
Inventor
Willy Blakely
Louise Reynolds
Lilian Cromie
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0610058A external-priority patent/GB0610058D0/en
Priority claimed from GB0610246A external-priority patent/GB0610246D0/en
Priority claimed from GB0708375A external-priority patent/GB2438287A/en
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of AP2008004691A0 publication Critical patent/AP2008004691A0/xx
Application granted granted Critical
Publication of AP2283A publication Critical patent/AP2283A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2008004691A 2006-05-19 2007-05-10 Stable aqueous suspension. AP2283A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0610058A GB0610058D0 (en) 2006-05-19 2006-05-19 Stable aqueous suspension
GB0610246A GB0610246D0 (en) 2006-05-23 2006-05-23 Stable aqueous suspension
GB0708375A GB2438287A (en) 2006-05-19 2007-04-30 Stable aqueous suspension
PCT/GB2007/001700 WO2007135362A2 (en) 2006-05-19 2007-05-10 Stable aqueous suspension having palatable taste

Publications (2)

Publication Number Publication Date
AP2008004691A0 AP2008004691A0 (en) 2008-12-31
AP2283A true AP2283A (en) 2011-10-31

Family

ID=38723651

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004691A AP2283A (en) 2006-05-19 2007-05-10 Stable aqueous suspension.

Country Status (8)

Country Link
EP (1) EP2034958B1 (es)
AP (1) AP2283A (es)
AR (1) AR061011A1 (es)
AU (1) AU2007253083B2 (es)
CA (1) CA2645205C (es)
PL (1) PL2034958T3 (es)
UY (1) UY30357A1 (es)
WO (1) WO2007135362A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
US20100179229A1 (en) * 2008-03-05 2010-07-15 Basf Se Method for modulating the taste of material compositions containing at least one high intensity sweetener (his)
EP3167875A1 (en) * 2009-05-27 2017-05-17 Alkermes Pharma Ireland Limited Reduction of flake-like aggregation in nanoparticulate meloxicam compositions
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
CN113925830B (zh) * 2017-08-24 2023-07-14 江苏恒瑞医药股份有限公司 一种包含美洛昔康的可注射的药物组合物及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1520578A1 (en) * 2003-09-30 2005-04-06 McNEIL-PPC, Inc. Medicinal suspensions
WO2006061351A1 (en) * 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1520578A1 (en) * 2003-09-30 2005-04-06 McNEIL-PPC, Inc. Medicinal suspensions
WO2006061351A1 (en) * 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam

Also Published As

Publication number Publication date
AP2008004691A0 (en) 2008-12-31
CA2645205C (en) 2012-12-04
AU2007253083B2 (en) 2012-07-19
EP2034958B1 (en) 2009-10-28
CA2645205A1 (en) 2007-11-29
AU2007253083A1 (en) 2007-11-29
EP2034958A2 (en) 2009-03-18
AR061011A1 (es) 2008-07-30
WO2007135362A2 (en) 2007-11-29
UY30357A1 (es) 2008-01-02
PL2034958T3 (pl) 2010-04-30
WO2007135362A3 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
AP2283A (en) Stable aqueous suspension.
AP2402A (en) Amine derivatives.
SI2046332T1 (sl) Koncentrirane metotreksatne raztopine
EG26602A (en) Water suspension formulation to exterminate pests
EP1994933A4 (en) AQUEOUS COMPOSITION
GB0605712D0 (en) Stabilizer arrangement
EP1899210A4 (en) SUSPENSION SYSTEMS
IL191644A0 (en) Aqueous suspension concentrates
ZA200803880B (en) Aqueous suspension concentrates
PL2054455T3 (pl) Stabilna wodna dyspersja żywic nowolakowych
GB0617290D0 (en) Suspension unit
GB2442716B (en) Independent rear suspension
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
ZA200807136B (en) Aqueous suspension concentrate
GB0610058D0 (en) Stable aqueous suspension
GB0610246D0 (en) Stable aqueous suspension
HK1105278A (en) Stable aqueous suspension
EP1867792A4 (en) STABILIZER
GB0607321D0 (en) Pivotless suspension
HK1111062A (en) Parasiticidal aqueous suspension
GB0615769D0 (en) Suspension
GB0623583D0 (en) Success, success, success
GB0623580D0 (en) Success, success, success, success
GB0604245D0 (en) Rubaneck.com
GB2422892B (en) Boilers